Commercialization and market acceptance risk
Revenue depends on customers choosing fertility control over traditional rodenticides.
- Scope
- ContraPest and Evolve sales
- Materiality
- high
SenesTech, Inc.
SenesTech, Inc. develops and commercializes fertility-control products for managing rat and mouse populations. Its portfolio includes ContraPest and the Evolve line, which are sold in the United States and through international distributors, with operations centered in Surprise, Arizona.
−286,8 %
62,5 %
−287,4 %
+19,6 %
12.61
11.36
| % | |
|---|---|
| ContraPest | 35% Liquid fertility-control product for rat population management. |
| Evolve Rat | 40% Fertility-control product for rat control across commercial channels. |
| Evolve Mouse | 20% Fertility-control product designed for mouse population management. |
| International distribution and support | 5% Sales through overseas distributors and related commercialization support. |
SenesTech sells to end users that need ongoing rodent population control, including pest management professionals,...
- Pest management professionalsprimary
Buy Evolve and ContraPest for field use in recurring rodent-control programs.
- Retail and e-commerce buyersprimary
Purchase rodent fertility-control products through online retail channels for self-directed use.
- Commercial and institutional facilitiessecondary
Use the products to manage rats and mice in buildings, campuses, and operations sites.
- Agricultural and food-related operatorssecondary
Buy to reduce rodent-driven contamination, feed loss, and infrastructure damage.
- International distributorsemerging
Distribute products into foreign markets after local regulatory and channel setup.
SenesTech is headquartered and manufactures in Surprise, Arizona, and its products are sold across the United States...
- •Headquarters and manufacturing are in Surprise, Arizona
- •Primary revenue base is the United States
- •ContraPest is registered nationwide plus U.S. territories
- •Evolve products have narrower state coverage than ContraPest
- •International sales depend on local distributors and approvals
SenesTech is focused on scaling its Evolve product family, expanding e-commerce and retail reach, and strengthening...
01
Expand Evolve commercializationshort-term
Evolve is the main growth engine and broadens the company's addressable market.
02
Broaden regulatory coveragemedium-term
State and foreign approvals determine where products can be sold.
03
Improve operating efficiencyshort-term
Manufacturing throughput and supplier economics affect scalability and margins.
04
Build channel partnershipsmedium-term
Partners help reach customers faster and support market education.
SenesTech depends on market acceptance of a relatively new fertility-control category, so adoption risk is central to...
Regulatory approval risk
Products require state and foreign registrations before they can be sold in many markets.
- Scope
- U.S. states and international jurisdictions
- Materiality
- high
Financing and liquidity risk
Commercial-stage losses and limited revenue can require external capital.
- Scope
- Equity issuance and warrant exercises
- Materiality
- high
Supply chain and manufacturing disruption
The company relies on third-party ingredients and a single manufacturing site.
- Scope
- Surprise, Arizona facility and raw materials
- Materiality
- high
Product misuse and liability risk
Off-label or improper use could trigger claims, investigations, or reputational damage.
- Scope
- End users, technicians, and service providers
- Materiality
- medium
Inventory valuation
Can create write-downs that reduce gross profit and earnings
Revenue recognition
Can shift quarterly revenue and comparability
Stock-based compensation
Raises operating expenses without immediate cash outflow
Held-to-maturity investments
Changes cash deployment and reported non-operating income
: 29.4.2026